Disclosures. Objectives. Impact of Obesity in Primary Care Practice and What To Do About It. Intuitive Surgical. Consultant

Similar documents
Management of Obesity. Objectives. Background Impact and scope of Obesity. Control of Energy Homeostasis Methods of treatment Medications.

WEIGHT LOSS/MANAGEMENT IS IT JUST ANOTHER PIPE DREAM?

Understanding Obesity: The Causes, Effects, and Treatment Options

Bariatric Surgery: Indications and Ethical Concerns

When Diet and Exercise Aren t Enough: Pharmacologic Management of Obesity

What Are the Effects of Weight Management Pharmacotherapy on Lipid Metabolism and Lipid Levels?

An Individualized Approach to Optimize Obesity Treatment Louis Aronne, MD

Bariatric surgery: Impact on Co-morbidities and Weight Loss Expectations ALIYAH KANJI, MD FRCSC MIS AND BARIATRIC SURGERY SEPTEMBER 22, 2018

Obesity: Pharmacologic and Surgical Management

Overview of Management of Obesity

Obesity and Bariatric Surgery

Obesity Pharmacotherapy: Options and Applications in Clinical Practice. Scott Kahan, MD, MPH

SURGICAL MANAGEMENT OF OBESITY. Anne Lidor, MD, MPH Professor of Surgery Chief, Division of Minimally Invasive and Bariatric Surgery

MEDICAL MANAGEMENT 101

Overweight and Obesity on the Menu. Marwan Akel, Pharm. D, MPH Clinical Assistant Professor School of Pharmacy Lebanese International University

Obesity D R. A I S H A H A L I E K H Z A I M Y

What is obesity? OBESITY. Obesity is a health issue in which someone has so much extra fat that it negatively impacts their health.

Treatment of Obesity SAJIDA AHAD MERCY GENERAL SURGERY

The New Trend of Anti-Obesity Drug

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs

Viriato Fiallo, MD Ursula McMillian, MD

WHAT S THE SKINNY ON WEIGHT LOSS MEDICATION SAFETY? January 25, 2019 Pennsylvania Pharmacists Association

Without Background for printing as Pocket Reference

Faculty/Presenter Disclosure

Learning Objectives. Currently Available Options. Update on Weight Loss Pharmacotherapy. Dan Bessesen, MD

Non-surgical Treatment for Adult Obesity

Update on the Recent Advances in Obesity Management. Benjamin O Donnell, MD Oct 5 th, 2018

Obesity Management in Type 2 Diabetes

Disclosures. Obesity and Its Challenges: Outline. Outline 5/2/2013. Lan Vu, MD Division of Pediatric Surgery Department of Surgery

Realistic Expectations: Drugs in the Treatment of Obesity. Lora Cotton, D.O. January 20, 2013

Frustrating Plateaus & Post Operative Weight Gain

Managing Obesity as a Disease. Disclosure. Objectives

Treating Obesity- NOT Just with Surgery

Medical Management of Obesity: Multidisciplinary Team and Pharmacologic Therapy. Shelby Sullivan University of Colorado School Of Medicine

The ABCDs of Obesity

Bariatric Surgery: A Cost-effective Treatment of Obesity?

Faculty Disclosures. Vera Tarman, MD, Author:

Obesity Management in Women

Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m.

Donna H Ryan, MD, FACP Pennington Biomedical Research Center Baton Rouge, LA.

Losing weight (and keeping it off) calls for changes to how you live your life, as well as to your connection to food and exercise.

Past, Present and Future of Pharmacotherapy for Obesity

Weight Loss Surgery. Outline 3/30/12. What Every GI Nurse Needs to Know. Define Morbid Obesity & its Medical Consequences. Treatments for Obesity

Update on Treating Obesity: A Multidisciplinary Approach. Marie Harkins, FNP BC, CDE Cayuga Center for Healthy Living

Obesity: The Role of Pharmacotherapy The Annual Women s & Children s Health Update Saturday 17th February 2018 Benefits of modest weight loss 3-10%

OBESITY AND WEIGHT LOSS SURGERY FOR THE PRIMARY CARE PHYSICIAN

Copyright 2017 by Sea Courses Inc.

Obesity and Weight Loss Surgery for the Primary Care Physician

Learning Objectives 11/8/2014. Obesity: Strategies to Tackle the Epidemic MA ACP Annual Scientific Meeting 1. Body Mass Index Calculation

Jordan Garrison Jr. MD, FACS, FASMBS

ADVANCE AT YOUR OWN PACE

Putting It in Perspective Using Medications for Chronic Weight Management. Donna H. Ryan, MD Pennington Biomedical Research Center

10/28/11. Bariatric Surgery: What the Primary Care Provider Should Know. Case Presentation: Rachelle

Lorcaserin (Belviq ) Rimonabant 2008 Sibutramine (Reductil, ) (World Health organization, WHO) 1996 WHO Orlistat (Xenical, )

3 Things To Know About Obesity Surgery

Anti-Obesity Agents Drug Class Prior Authorization Protocol

FDA approves Belviq to treat some overweight or obese adults

Technique. Matthew Bettendorf, MD Essentia Health Duluth Clinic. Laparoscopic approach One 12mm port, Four 5mm ports

Navigating the new weight loss medications Jacqueline Jordan Spiegel, MS, PA-C, DFAAPA Associate Professor Midwestern University

An Introduction to Bariatric Surgery

A Bariatric Patient in my Waiting Room: Choosing the Right Patient for the Right Operation: Bariatric Surgery Indications

CURRENT STRATEGIES IN MANAGEMENT OF OBESITY. Prevalence of Obesity (Adults)

6/23/2011. Bariatric Surgery: What the Primary Care Provider Should Know. Case Presentation: Rachelle

OBESITY:Pharmacotherapy Vs Surgery

The US FDA, EMA and our TGA use these cutpoints in assessing drug efficacy. Disclosures: Professor John B Dixon

Bariatric Intake Form

Chapter 9 Weight Control: Overweight and Underweight

Dr. Shahebina Walji MD. Clinical Lecturer, University of Calgary Medical Director, Calgary Weight Management Centre

Empower Preventive Medicine. Timothy J. McCormick, DO, MPH 4221 Baymeadows Suite 6 Jacksonville, FL

Certified Bariatric Nurse Review Course. Session 1

Where are We Now? Editor s Note: Who Qualifi es for Obesity Medications?

Developing nations vs. developed nations Availability of food contributes to overweight and obesity

ACHIEVING HEALTH: AGENDA: Achieving Health: A Look at Your Weight Management Options

Healthy weight 18.5 to <25. Diabetes Dispatch. Overweight 25 to <30. Obese class I 30 to <35. Obese class II 35 to <40

Bariatric Surgery and Post Operative Patient Care Alisha M. Fuller DNP, CBN, FNP BC Tristate Bariatrics Clinical Director, NP Manager

Current Management of Obesity

Update on Bariatric Surgery. Learning Objectives: At the end of this lecture you should be able to: Currently Available Options

Bariatric Surgery. The Oregon Bariatric Center Surgical Team

Disclosures OBESITY. Overview. Obesity: Definition. Prevalence of Obesity is Rising. Obesity as a Risk Factor. None

The Implications of Obesity as a Disease

BASELINE TRAITS AS PREDICTORS OF SUCCESS IN MEDICAL WEIGHT MANAGEMENT

Index. Note: Page numbers of article titles are in boldface type.

APhA March 2016 Annual Meeting Obesity Cases

Disclosures. Start the Conversation. Agenda. Behavioral and Medical Approaches for Obesity Treatment 10/18/2014

When Lifestyle Modification Therapy is Not Enough: Pharmacotherapy for Severe/Complicated Pediatric Obesity

Commonly Performed Bariatric Procedures in Singapore. Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital

Obesity in Children. JC Opperman

MANAGEMENT OF OBESITY: A

Understanding. Obesity. An educational resource provided by the Obesity Action Coalition

Surgical Therapy for Morbid Obesity. Janeen Jordan, PGY 5 Surgical Grand Rounds April 7, 2008

Benefits of Bariatric Surgery

A SYSTEMATIC APPROACH TO

NEW DEVELOPMENTS IN ASSESSMENT AND TREATMENT OF OBESITY

CURRENT STATE. of the Treatment of Obesity

I. ALL CLAIMS: HEALTH CARE PROFESSIONALS

10/29/2011. Metabolic, Obstetric, and Gynecological Consequences of Bariatric Surgery. Case Presentation: Rachelle. Jonathan Carter, MD

OBESITY IN TYPE 2 DIABETES

Bariatric Surgery: The Primary Care Approach

CURRENT STRATEGIES IN OBESITY

Disclosure Medtronic - Speaker/ Research Grant/ Robotics Advisory Board Gore - Education Grant/ Speaker Teleflex - Consultant Da Vinci - Proctor

Transcription:

Disclosures Intuitive Surgical Consultant Stephen Archer, MD, FACS, FASMBS Director, Bariatric Surgery, St. Charles Medical Center Bend, OR Grand Rounds June 15, 2018 2 Objectives Impact of Obesity in Primary Care Practice and What To Do About It Recognize the role obesity plays in the pathogenesis and epidemiology of common problems such as diabetes, cancer, etc. Describe the impact of medical treatments for treating obesity including interactions and side effects. Review bariatric surgery indications and results with respect to common ailments in primary care practice Discuss prevention strategies

Prevalence of Self-Reported Obesity Among U.S. Adults by State and Territory, BRFSS, 2016 Obesity Trends 6 Trend In Obesity Rate in Oregon Oregon WIC Kids 2-4 y.o. Obesity Rates Diabetes Rates 8

Body Mass Index vs. Mortality Relative Mortality Rate Exponential Increase in Risk 400 350 300 250 High risk Medium risk Low risk 200 150 100 50 0 16 19 22 25 28 31 34 37 40 45 BMI How Did We Get Here? Source: NIH, NEJM, 1995. 10 What is the furthest you can be from a Big Mac in the United States? How did we get here? We don t move as much 107 Miles

What Causes Obesity? Top 10 Family Practice Diagnoses Genetic predisposition Obesity gene Physiologic Hormones: ghrelin Decreased stretch receptors Loss of satiety mechanism (hypothalamus) Behavioral Family tradition Food to comfort child Addiction! Socioeconomic! Cultural views! Fast Food Nation! Psychosocial! Coping mechanism (i.e. stress, abuse)! Societal! Technology has decreased energy expenditure! Fast food--starting in school Hypertension ension Hyperlipidemia pidemia Diabetes es Back pain Anxiety y Obesity y Allergic rhinitis Reflux esophagitis Respiratory Problems Hypothyroidism 2018 Practice Fusion, Inc. 14 Co-morbidities of Obesity Spiritual Morbidity of Obesity Diabetes Heart disease Hypertension Hyperlipidemia Asthma Sleep apnea Gallstones Steatohepatitis Urinary incontinence Acid reflux Arthritis and gout Infertility and PCOS High risk pregnancy DVT/PE Depression Immobility Cancer Breast Colorectal Prostate Endometrial Accident prone Rashes All the medical stuff, but also Isolation We get sick when we are alone and we get better when connected. Food Addiction 16

Oxidative stress is increased in metabolic syndrome and type 2 diabetes mellitus (T2DM) and this appears to underlie the development of cardiovascular disease, T2DM and diabetic Pathway complications. to Increased T2DM oxidative stress appears to be a deleterious factor leading to insulin resistance, dyslipidemia, β-cell dysfunction, impaired glucose tolerance and ultimately leading to T2DM Two Hit Theory: Genes + Environment 1 2* Obesogenic Environment World J Diabetes. 2015 Apr 15; 6(3): 456 480. 17 World J Diabetes. 2015 Apr 15; 6(3): 456 480. Closed Loop NAFLD and Metabolic Syndrome Adipocytes Not simply storage cells Metabolically active Pro-inflammatory World J Gastroenterol. 2017 Sep 28; 23(36): 6571 6592. 19 The fields of immunology and metabolism are rapidly converging on adipose tissue. During obesity, many immune cells infiltrate or populate in adipose tissue and promote a low-grade chronic inflammation. Studies to date have suggested that perturbation of inflammation is critically linked to nutrient metabolic pathways and to obesity-associated complications such as insulin resistance and type 2 diabetes. Annu Rev Nutr. 2012 Aug 21; 32: 261 286. 20

Treatment of Obesity When you treat obesity you are treating the underlying problem for the morbidities Relationship to food and life is fundamental Education for patients Advocacy for the public health Medications Surgery Orlistat (Xenical) Weight Loss Medications Lipase inhibitor, reduced absorption of fat by 30% Lorcaserin (Belviq), Stimulates 5-HT (serotonin) 2C receptors on anorectic POMC neurons close to fenfluramine, but not quite, decreased appetite, induces satiety Phentermine/Topiramate (Qsymia) Centrally acting appetite suppressant (phentermine) and increased energy utilization/inhibition of appetite Bupropion/Naltrexone (Contrave) Dopamine/norepi uptake inhibitor (stimulates POMC) + opioid receptor antagonist Liraglutide (Saxenda) GLP-1 agonist similar to other meds for T2D, induces satiety 21 Drugs. 2015; 75(9): 935 945. 22 2018 Weight Loss Medications Medication Mechanism of Action Side Effects Interaction/Warnings Cost/month* Note An Aside Orlistat (Xenical) Lipase inhibitor, 30% less fat absorbed Diarrhea, oily stools, etc Avoid w cyclosporin, Add MVI $170.00 Lorcaserin (Belviq) 5-HT (serotonin) 2C agonist, POMC neurons: anorexia/ satiety Phentermine/ Centrally acting Topiramate anorectic, increased (Qsymia) metabolism, satiety Buproprion/ Dop/NE uptake Naltrexone inhibitor (POMC) + (Contrave) opioid receptor agonist constipation, cough, dizziness, dry mouth, fatigue, nausea constipation, dizziness, dry mouth, taste changes, insomnia constipation, dizziness, dry mouth, headache, increased BP, tachycardia, liver damage Serotonin syndrome possible w other antidepressants? heart valve issues Avoid w glaucoma/ hyperthyroidism. Exacerbate HTN, mania, arrhythmias BIRTH DEFECTS Can t use w opioids, increased suicidal thoughts, avoid during etoh withdrawal $270.00 Safe long term $200.00 Safe long term, taper off prior to surgery, Controlled so monthly Rx. $250 Safe long term use, $100.00 w coupon taper off. (components If emergency ordered separately surgery, fentanyl much less) must be used. Hypothalamic pro-opiomelanocortin piom (POMC) neurons promote satiety. Cannabinoid noid receptor 1 (CB1R) is critical for the central regulation of food intake.... The Pomc gene encodes both the anorexigenic peptide α-melanocyte-stimulating hormone, and the opioid peptide β-endorphin. Liraglutide (Saxenda) GLP-1 agonist, satiety and anorexia Injection only, nausea, diarrhea, constipation, and pain, headache, tachycardia possible role in pancreatitis $1280.00 FDA approved for 12 weeks only *Coupons often available from drug companies Hypothalamic pro-opiomelanocortin (POMC) neurons promote satiety 24

Probability of Achieving 5% Weight Loss and Possibility of Adverse Events Case For/Against Bariatric Surgery For Against Decreased mortality Expensive Resolution of diabetes, HTN Weight regain up to 20% etc Unpredictable results Improved quality of life Complications Halo effect in families Higher death rate from suicide Safe Addiction transfer <1% leak rate Significant weight gain occurs continuously in patients after reaching.5% mortality ty rate the nadir weight following gastric Best treatment t currently bypass. Despite this weight gain, the long-term mortality remains low at available 3.1%. JAMA. 2016 Jun 14; 315(22): 2424 2434 25 26 How Bariatric Surgery Works 28

Current Most-Used Bariatric Techniques Leak Test in the OR Leak is one of several possible life threatening complications Vertical Sleeve Gastrectomy Roux-en-Y Gastric Bypass Restrictive Remove approximately threefourths of the stomach Malabsorptive & Restrictive Bypass a portion of the small intestine and create a 15-30cc stomach pouch Long Term Results Gastric Bypass Very Low Calorie Diet +/- Behavioral Modification 5 Weight change (kg) 0-5 -10-15 -20 Very-low-calorie diet Modified diet plus behavior therapy Very-low-calorie diet plus behavior therapy intervention 1 2 3 Years after intervention 4 5

Oncologic Model of Obesity Care Neoadjuvent medical therapy prior to surgery? Surgery Adjuvent therapy at the nadir of weight loss or before? Summit BMC has added an internist to bariatric program https://doi.org/10.1016/j.soard.2016.10.018 Firefighting vs. Prevention I do obesity treatment. You probably do too. We are standing on the edge of a fire How do we prevent the fire? 33 34 Obesity Prevention Real food not processed food, prepared at home Know your farmer and rancher or be your own farmer Advocate for better school lunches Zero sugar sweetened beverages (Believe that Big Food is out there) Less screen, more activity Be a part of civic discussions about city and neighborhood planning (Obesogenic environment) Teach children how to eat and cook and sleep Weight loss surgery in parent may prevent transmission of obesity to their children (Arch Surg. 2011;146(10):1185-1190) Be aware of adverse childhood events (ACE s) Obesity Prevention Epigenetics (selective gene expression) Avoid prenatal weight gain Pediatrics 118(6):e1644-9 Encourage breast feeding (data is +/-) Support the gut biome Example growing body of evidence indicating that common food additives can push our microbial communities in unhealthy directions, not only potentially aiding the emergence of new pathogens, but also encouraging diseases like obesity, diabete and inflammatory bowel disease. EAT. MOVE. CONNECT. 35 https://www.nytimes.com/2018/04/06/opinion/sunday/germs-microbes-processed-foods.html 36

Thank you St. Charles is accredited by the American College of Surgeons for Bariatric Surgery Summit Weight Loss is the only comprehensive (med + surg) on this side of the Cascades This is my cell phone number: 541-460-3773 I will see any obese patient for any reason, regardless of issue, regardless of what operation or where. Summit Weight Loss: 541.706.6518 Medical and Surgical Weight Management 37